首页> 外国专利> Quinoline and quinazoline compounds useful in therapy especially for the treatment of benign prostatic hyperplasia

Quinoline and quinazoline compounds useful in therapy especially for the treatment of benign prostatic hyperplasia

机译:喹啉和喹唑啉化合物可用于治疗,尤其用于治疗良性前列腺增生

摘要

Compounds of formula I,whereinR1 represents C1-4 alkoxy optionally substituted by one or more fluorine atoms;R2 represents H or C1-4 alkoxy optionally substituted by one or more fluorine atoms;R3 represents a 5- or 6-membered heterocyclic ring, the ring being optionally substituted;R4 represents a 4-, 5-, 6-, or 7-membered heterocyclic ring, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring, the ring system as a whole being optionally substituted;X represents CH or N; andL is absent, or represents a cyclic group of formula Ia, or represents a chain of formula Ib,and pharmaceutically acceptable salts thereof; are useful in therapy, in particular in the treatment of benign prostatic hyperplasia.
机译:式I的化合物,其中R 1代表任选地被一个或多个氟原子取代的C 1-4烷氧基; R 2代表任选地被一个或多个氟原子取代的H或C 1-4烷氧基; R 3代表5或6元杂环,环被任选地取代; R 4代表4、5、6或7元杂环,该环任选地稠合至苯环或5或6元杂环,整个环系统任选地被取代; X代表CH或N;和L不存在,或代表式Ia的环状基团,或代表式Ib的链,及其药学上可接受的盐;可用于治疗,特别是良性前列腺增生的治疗。

著录项

  • 公开/公告号DK0968208T3

    专利类型

  • 公开/公告日2003-07-28

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号DK19980904058T

  • 申请日1998-01-06

  • 分类号C07D409/04;A61K31/47;A61K31/505;C07D401/04;C07D401/14;C07D405/04;C07D413/04;C07D471/04;

  • 国家 DK

  • 入库时间 2022-08-22 00:03:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号